Table 1 Patients’ characteristics
Variables | Patients (n) | % |
|---|---|---|
Total | 41 | 100 |
Age, median (years,range) | 63 (30–80) | |
FIGO stage | ||
IIIB | 2 | 4.9 |
IIIC | 18 | 43.9 |
IVA | 6 | 14.6 |
IVB | 15 | 36.6 |
Histology | ||
High grade serous | 37 | 90.2 |
Low grade serous | 4 | 9.8 |
Treatment strategy | ||
Primary debulking surgery | 12 | 29.3 |
Neoadjuvant chemotherapy | 29 | 70.7 |
Interval debulking surgery | 24 | 58.5 |
PDS outcome | ||
No residual tumor | 3 | 25.0 |
Residual tumor size < 1 cm | 4 | 33.3 |
Residual tumor size > 1 cm | 5 | 41.7 |
IDS outcome | ||
No residual tumor | 6 | 25.0 |
Residual tumor size < 1 cm | 17 | 70.8 |
Residual tumor size > 1 cm | 1 | 4.2 |
Primary treatment outcome | ||
Complete response | 20 | 48.8 |
Partial response | 9 | 22.0 |
Stable disease | 0 | 0 |
Progressive disease | 12 | 29.2 |
Recurrence rate after completion of first line therapy (N = 29) | ||
All patients | 26 | 89.7 |
Complete response | 14 | 46.2 |
Partial response | 12 | 53.8 |